【心臟】《Nimbus》攜手《Lilly》將「AMP活化蛋白激酶」應用於治療心臟代謝疾病
文章出處
Businesswire
原文標題
Nimbus Therapeutics Achieves Research Milestone in Collaboration with Lilly
Twitter
https://x.com/aimedadviser/status/1894906916234764374
文章序號
7397
智醫科學－AI醫療技術、應用與市場動態
Copyright ©2025 智醫科學 MEDai.tw All rights reserved.
The content of
this site is intended for healthcare and medical professionals.
